Estados financieros detallados de Agenus Inc. (AGEN): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $76.4M | $60.2M | $53.1M | $61.8M | $99.9M | $291.9M | $178.7M | $76.1M | $40.4M | $3.0M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | $15.0M | $14.7M | 0 | 0 | 0 |
| Cuentas por Cobrar | $11.4M | $1.1M | $938141 | $16.3M | $1.2M | $1.5M | $2.7M | $25.8M | $407000 | $1.8M |
| Inventario | $88200 | $79491 | $55491 | $7.4M | 0 | $20.4M | $13.8M | 0 | 0 | 0 |
| Activos Corrientes | $91.3M | $73.6M | $74.8M | $86.5M | $113.8M | $332.0M | $213.1M | $112.4M | $45.6M | $133.4M |
| Inmovilizado Material | $25.6M | $26.2M | $25.1M | $33.7M | $60.3M | $91.1M | $164.3M | $163.0M | $147.4M | $24.2M |
| Fondo de Comercio | $22.4M | $23.0M | $22.9M | $23.2M | $25.5M | $24.9M | $25.5M | $24.7M | $24.1M | $24.1M |
| Activos Intangibles | $16.4M | $31.8M | $12.3M | $10.5M | $10.9M | $8.5M | $6.2M | $4.4M | $3.4M | $3.0M |
| Activos Totales | $157.0M | $138.4M | $136.4M | $155.3M | $214.5M | $466.0M | $413.6M | $313.9M | $226.3M | $226.8M |
| Cuentas por Pagar | $5.4M | $8.1M | $13.6M | $13.6M | $17.0M | $30.5M | $40.9M | $61.4M | $61.5M | $83.0M |
| Deuda a Corto | $146061 | $20.6M | $146000 | $646000 | $833000 | $728000 | $575000 | $146000 | $2.7M | $155.1M |
| Pasivos Corrientes | $40.9M | $56.4M | $68.1M | $122.2M | $129.9M | $156.9M | $189.0M | $255.9M | $221.4M | $323.5M |
| Deuda a Largo | $130.5M | $142.4M | $13.21B | $13.4M | $18.9M | $12.8M | $12.6M | $12.8M | $30.5M | $169.7M |
| Pasivos Totales | $196.1M | $214.2M | $310.9M | $386.7M | $426.0M | $418.0M | $468.5M | $462.3M | $532.7M | $504.7M |
| Reservas | -$905.3M | -$1.03B | -$1.18B | -$1.28B | -$1.47B | -$1.49B | -$1.71B | -$1.96B | -$2.18B | -$2.18B |
| Patrimonio Neto | -$39.1M | -$75.8M | -$172.5M | -$225.4M | -$203.7M | $34.4M | -$61.3M | -$160.3M | -$326.4M | -$271.1M |
| Deuda Total | $130.7M | $163.0M | $13.4M | $23.4M | $55.7M | $58.3M | $78.4M | $93.2M | $94.9M | $334.9M |
| Deuda Neta | $54.3M | $102.8M | -$39.7M | -$38.4M | -$44.1M | -$248.6M | -$114.9M | $17.1M | $54.4M | $331.9M |
| Capital Circulante | $50.5M | $17.1M | $6.7M | -$35.7M | -$16.1M | $175.0M | $24.2M | -$143.5M | -$175.8M | -$190.1M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -38.12% |
| Rentabilidad sobre capital invertido | -129.48% |
| Rentabilidad sobre activos | 53.28% |
| Margen bruto | 75.63% |
| Margen operativo | 27.28% |
| Margen neto | 69.34% |
Salud financiera
| Deuda / Patrimonio | -0.20 |
| Ratio corriente | 0.34 |
Empresas relacionadas: ABOS · FATE · HURA · INO · IRD · PLRX · SEER
Explorar sector: Healthcare · Biotechnology
Más secciones de AGEN: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones